Centuple Global Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 510537, "name": "Centuple Global", "stock_name": "Centuple Global", "full_name": "Centuple Global Ltd", "name_url": "stocks-analysis/centuple-global", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "42.99", "chg": -0.61, "chgp": "-1.4%", "dir": -1, "prev_price": "43.60", "mcapval": "25.00 Cr", "mcap": "Micro Cap", "scripcode": 531099, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE396H01019", "curr_date": "Jun 09, 03:30 PM", "curr_time": "07:59 AM", "last_traded_at": "Jun 09, 03:30 PM IST", "bse_nse_vol": "2.1 k", "exc_status": "Active", "traded_date": "Jun 09, 2026", "traded_date_str": "2026 06 09", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/centuple-global-510537-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Are Checkpoint Trends Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-checkpoint-trends-ltd-latest-results-good-or-bad-4024803", "imagepath": "", "date": "2026-05-31 19:20:56", "description": "Checkpoint Trends Ltd's latest financial results for Q4 FY26 present a complex picture of rapid revenue growth juxtaposed with significant challenges in profitability. The company reported net sales of ₹279.41 crores, reflecting a remarkable year-on-year revenue growth of 111,664% from ₹0.25 crores in Q4 FY25. This surge indicates a dramatic transformation in the company's business operations, suggesting successful scaling efforts in the pharmaceutical trading segment.\n\nHowever, despite this impressive revenue increase, Checkpoint Trends Ltd faced a net loss of ₹0.48 crores in the latest quarter, a stark contrast to the profit of ₹0.06 crores reported in the same quarter last year. The operating margin also turned negative at -0.14%, a significant decline from 36.0% in Q4 FY25. This deterioration in margins raises concerns about the company's ability to convert its top-line growth into bottom-line profitabi..." }, { "title": "Centuple Global Q4 FY26: Explosive Revenue Growth Masks Profitability Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/centuple-global-q4-fy26-explosive-revenue-growth-masks-profitability-concerns-4024538", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CentupleGlobal_quaterlyResult_4024538.png", "date": "2026-05-30 23:49:22", "description": "Centuple Global Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹26.00 crores, reported extraordinary revenue growth in Q4 FY26 (Mar'26), though profitability turned sharply negative. The company posted net sales of ₹279.41 crores for the quarter, representing a staggering 111,664.00% year-on-year surge, whilst net profit swung to a loss of ₹0.48 crores from a profit of ₹0.06 crores in the year-ago period. Following the results announcement, the stock traded at ₹46.49, down 67.80% from its 52-week high of ₹144.40." }, { "title": "When is the next results date for Checkpoint Trends Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-checkpoint-trends-ltd-4015111", "imagepath": "", "date": "2026-05-26 23:18:40", "description": "The next results date for Checkpoint Trends Ltd is scheduled for 30 May 2026...." }, { "title": "Checkpoint Trends Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-is-rated-sell-3992606", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CheckpointTrend_mojoScore_3992606.png", "date": "2026-05-15 10:10:02", "description": "Checkpoint Trends Ltd is rated Sell by MarketsMOJO, with this rating last updated on 17 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 May 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Checkpoint Trends Ltd Downgraded to Sell Amid Institutional Exit Despite Strong Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-downgraded-to-sell-amid-institutional-exit-despite-strong-financials-3953338", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CheckpointTrend_mojoScore_3953338.png", "date": "2026-04-20 08:08:53", "description": "Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Apr 2026. Despite strong financial performance and attractive valuation metrics, concerns over institutional participation and technical indicators have weighed on the outlook, prompting a reassessment of the stock’s prospects." }, { "title": "Checkpoint Trends Ltd Gains 17.44%: 2 Key Factors Driving the Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/checkpoint-trends-ltd-gains-1744-2-key-factors-driving-the-move-3952641", "imagepath": "", "date": "2026-04-18 17:03:53", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Apr 13:</strong> Upgrade to Hold rating as technicals and financials improve</p>\n <p><strong>Apr 15:</strong> Stock jumps 5.00% amid strong volume</p>\n <p><strong>Apr 16:</strong> Continued gains with 4.99% rise</p>\n <p><strong>Apr 17:</strong> Death Cross formation signals potential bearish trend</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.52.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.61.36</div><div class=\"stat-..." }, { "title": "Checkpoint Trends Ltd Forms Death Cross Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/checkpoint-trends-ltd-forms-death-cross-signalling-potential-bearish-trend-3951636", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CheckpointTrend_dealthcross_3951636.png", "date": "2026-04-17 18:00:15", "description": "Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock's medium to long-term momentum despite its recent volatile performance." }, { "title": "Checkpoint Trends Ltd Upgraded to Hold as Technicals and Financials Improve", "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-upgraded-to-hold-as-technicals-and-financials-improve-3944144", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CheckpointTrend_mojoScore_3944144.png", "date": "2026-04-13 08:09:00", "description": "Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 10 April 2026. This change reflects a combination of improved technical indicators, robust financial performance, attractive valuation metrics, and a positive quality assessment, signalling a cautious but optimistic outlook for investors." }, { "title": "Checkpoint Trends Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-downgraded-to-sell-amid-mixed-technicals-and-valuation-concerns-3935722", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CheckpointTrend_mojoScore_3935722.png", "date": "2026-04-07 08:18:26", "description": "Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 April 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals, highlighting both strengths and emerging concerns in the company’s outlook." } ], "total": 288, "sid": "510537", "stock_news_url": "https://www.marketsmojo.com/news/centuple-global-510537" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "02-Jun-2026", "details": "Newspaper publication", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting", "datetime": "30-May-2026", "details": "Outcome of Board Meeting", "source": "BSE" }, { "caption": "Audited Financial Result For The Quarter And Year Ended March 31 2026", "datetime": "30-May-2026", "details": "Audited financial result for the quarter and year ended March 31 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Apr 13: Upgrade to Hold rating as technicals and financials improve

Apr 15: Stock jumps 5.00% amid strong volume

Apr 16: Continued gains with 4.99% rise

Apr 17: Death Cross formation signals potential bearish trend

Read full news article

Checkpoint Trends Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-04-17 18:00:15

Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock's medium to long-term momentum despite its recent volatile performance.

Read full news article

Checkpoint Trends Ltd Upgraded to Hold as Technicals and Financials Improve

2026-04-13 08:09:00

Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 10 April 2026. This change reflects a combination of improved technical indicators, robust financial performance, attractive valuation metrics, and a positive quality assessment, signalling a cautious but optimistic outlook for investors.

Read full news article

Checkpoint Trends Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns

2026-04-07 08:18:26

Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 April 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals, highlighting both strengths and emerging concerns in the company’s outlook.

Read full news article